Pediatrics News

Children from historically marginalized racial and ethnic groups and low-income households were less likely to receive vision screening and establish care with a specialist, according to a research letter published in JAMA Ophthalmology.

FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Marie-José Tassignon, MD, PhD, speaks about a new ESCRS registry and invites colleagues to collaborate.

FRANKFURT, Germany — In children’s eyes with insufficient capsular support, intrascleral IOL fixation with the Yamane technique leads to good visual outcomes and few intraoperative and postoperative complications.

Children in the U.S. are not receiving timely management for refractive error or ocular conditions, according to research conducted by CooperVision and presented at the 2024 Global Specialty Lens Symposium.

The FDA has granted breakthrough device designation to SightGlass Vision’s diffusion optics technology spectacle lenses, which are designed to slow myopia progression in children.

Hoot Health has announced the launch of Hoot Referrals, the company’s marketing automation solution designed help optometrists connect with nearby pediatricians through targeted communications about myopia awareness.

Worse best-corrected visual acuity, longer axial length, faster axial length elongation and severe myopic maculopathy were reported risk factors for myopic maculopathy progression in children, according to research in JAMA Ophthalmology.

Treatment with MiSight 1 day contact lenses reduced axial growth in children by 0.52 mm compared with predicted accumulated growth of untreated eyes, according to 6-year data published in Ophthalmic and Physiological Optics.

WAILEA, Hawaii — Pediatric retina is a difficult field with high stakes. Here at the Hawaiian Eye 2024 meeting, a specialist shared pearls on what any ophthalmologist who deals with pediatric patients should not miss.

WAILEA, Hawaii — In this Healio video perspective from Hawaiian Eye 2024, Nick Ruth, MBA, of Sydnexis, delivers an update on SYD-101, the company’s upcoming treatment for progressive myopia in pediatric patients.